An evidence-based, peer-reviewed journal for practicing clinicians in the field of dermatology
Issue link: https://jcadonline.epubxp.com/i/934167
37 JCAD JOURNAL OF CLINICAL AND AESTHETIC DERMATOLOGY February 2018 • Volume 11 • Number 2 R E V I E W apoptosis through mitochondrial pathway and caspases activation in human melanoma cells. Mol Biol Rep. 2014:42(1);267–275. 44. Fritz H. Soy, red clover, and isoflavones and breast cancer: A systematic review. PloS One. 2013;8(11):e81968. 45. Wallo W. Efficacy of a soy moisturizer in photoaging: a double-blind, vehicle-controlled, 12-week study. J Drugs Dermatol. 2007;6(9): 917–922. 46. Gopaul R, Knaggs HE, Lephart ED. Biochemical investigation and gene analysis of equol: a plant and soy-derived isoflavonoid with antiaging and antioxidant properties with potential human skin applications. Biofactors. 2012;38(1):44–52. 47. Mahmoud AM, Yang W, Bosland MC. Soy isoflavones and prostate cancer: A review of molecular mechanisms. J Steroid Biochem Mol Biol. 2014;140:116–132. 48. Callender VD. Postinflammatory hyperpigmentation etiologic and therapeutic considerations. Am J Clin Dermatol. 2011;12(2):87–99. 49. Chen N. Nondenatured soy extracts reduce UVB-induced skin damage multiple mechanisms. Photochem Photobiol. 2008;84(6):1551–1559. 50. Huang M, Xie J, Lin CB, et al. Inhibitory effect of topical applications of nondenatured soymilk on the formation and growth of UVB-induced skin tumors. Oncol Res. 2004;14(7–8):387–397. 51. Hermanns JF, Petit L, Piérard-Franchimont C, et al. Assessment of topical hypopigmenting agents on solar lentigines of asian women. Dermatology. 2002;204(4):281–286. 52. Hermanns JF, Petit L, Martalo O, et al. Unraveling the patterns of subclinical pheomelanin-enriched facial hyperpigmentation: effect of depigmenting agents. Dermatology. 2000;201(2):118–122. 53. Pierard G, Graf R, Gonzalez R, Cauwenbergh W. Effects of soy on hyperpigmentation in Caucasian and Hispanic populations. 59th annual meeting of the American Academy of Dermatology; March 2–7, 2001; Washington, DC. 54. Moores J. Vitamin C: A wound healing perspective. Br J Community Nurs. 2013;Suppl:S6, S8–S11. 55. Panich U. Inhibition of UVA-mediated melanogenesis by ascorbic acid through modulation of antioxidant defense and nitric oxide system. Arch Pharm Res. 2011;34(5):811–820. 56. Kim W. Efficacy and safety of a new superficial chemical peel using alpha-hydroxy acid, vitamin C and oxygen for melasma. J Cosmet Laser Ther. 2013;15(1):21–24. 57. Soliman MM, Ramadan SA, Bassiouny DA, Abdelmalek M. Combined trichloroacetic acid peel and topical ascorbic acid versus trichloroacetic acid peel alone in the treatment of melasma: a comparative study. J Cosmet Dermatol. 2007;6(2):89–94. 58. Khemis A, Cabou J, Dubois J, Ortonne J. A randomized controlled study to evaluate the depigmenting activity of l-ascorbic acid plus phytic acid - serum vs. placebo on solar lentigines. J Cosmet Dermatol. 2011;10(4):266–272. 59. Huh C, Seo K, Park J, et al. A randomized, double-blind, placebo-controlled trial of vitamin C iontophoresis in melasma. Dermatology. 2003;206(4):316-320. 60. Taylor MB, Yanaki JS, Draper DO, et al. Successful short-term and long-term treatment of melasma and postinflammatory hyperpigmentation using vitamin c with a full-face iontophoresis mask and a mandelic/ malic acid skin care regimen. J Drugs Dermatol. 2013;12(1):45–50. 61. Halder RM, Grimes PE, McLaurin CI, et al. Incidence of common dermatoses in a predominantly black dermatologic practice. Cutis. 1983;32(4):388, 390. 62. Alexis AF, Sergay AB, Taylor SC. Common dermatologic disorders in skin of color: a comparative practice survey. Cutis. 2007;80(5):387–94. 63. Draelos ZD, Yatskayer M, Bhushan P, et al. Evaluation of a kojic acid, emblica extract, and glycolic acid formulation compared with hydroquinone 4% for skin lightening. Cutis. 2010;86(3):153–158. JCAD